As of November 2024, Protalix BioTherapeutics has a market cap of $79.52M. This makes Protalix BioTherapeutics the world's 22521th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $110.52M | -14.89% |
2023 | $129.85M | 29.93% |
2022 | $99.94M | 65.06% |
2021 | $60.55M | -77.13% |
2020 | $264.82M | 10.67% |
2019 | $239.28M | 5.81% |
2018 | $226.15M | -53.03% |
2017 | $481.48M | 46.67% |
2016 | $328.28M | -55.88% |
2015 | $744.11M | -44.57% |
2014 | $1.34B | -52.70% |
2013 | $2.84B | -25.05% |
2012 | $3.79B | 5.27% |
2011 | $3.60B | -50.60% |
2010 | $7.28B | 50.76% |
2009 | $4.83B | 259.78% |
2008 | $1.34B | -45.88% |
2007 | $2.48B | -79.64% |
2006 | $12.18B | -60.71% |
2005 | $31.00B | 2025.00% |
2004 | $1.46B | -50.00% |
2003 | $2.92B | 263.64% |
2002 | $802.47M | -52.17% |
2001 | $1.68B | 22.67% |
2000 | $1.37B | -78.57% |
1999 | $6.38B | -61.11% |
1998 | $16.41B | - |